Insider · CIK 0001799167
Jesse Shefferman
Files at TARA (Protara Therapeutics, Inc.). First filing -, latest -.
Jesse Shefferman files SEC Form 4 as CEO, president and director at TARA (Protara Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jesse Shefferman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 29, 2026 | TARA PROTARA THERAPEUTICS, INC. | 215,687 0.38% of outstanding | $882k | Jun 29, 2026 | none |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | TARA Protara Therapeutics, Inc. | FTax withholding Common Stock | -8,732 | $6.67 | $58k | 1,021,832 | Jan 27, 2026 |
| Jan 20, 2026 | TARA Protara Therapeutics, Inc. | FTax withholding Common Stock | -16,322 | $5.60 | $91k | 1,030,564 | Jan 22, 2026 |
| Jan 16, 2026 | TARA Protara Therapeutics, Inc. | AGrant or award Common Stock | +87,000 | $0.00 | $0 | 1,046,886 | Jan 21, 2026 |
| Jan 16, 2026 | TARA Protara Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +524,000 | $0.00 | $0 | 524,000 | Jan 21, 2026 |
| Jun 24, 2025 | TARA Protara Therapeutics, Inc. | GGift Common Stock | -300,000 | $0.00 | $0 | 659,886 | Jul 7, 2025 |
| Jun 26, 2025 | TARA Protara Therapeutics, Inc. | GGift Common Stock | -1,700 | $0.00 | $0 | 976,853 | Jun 30, 2025 |
| Jun 26, 2025 | TARA Protara Therapeutics, Inc. | GGift Common Stock | -3,400 | $0.00 | $0 | 973,453 | Jun 30, 2025 |
| Jun 27, 2025 | TARA Protara Therapeutics, Inc. | GGift Common Stock | -10,200 | $0.00 | $0 | 963,253 | Jun 30, 2025 |
| Jun 27, 2025 | TARA Protara Therapeutics, Inc. | GGift Common Stock | -3,367 | $0.00 | $0 | 959,886 | Jun 30, 2025 |
Questions about Jesse Shefferman
Answered from the filings on this page, as of the latest one.
Is Jesse Shefferman buying or selling?
Jesse Shefferman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jesse Shefferman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jesse Shefferman has 0.
Where does Jesse Shefferman file Form 4?
Jesse Shefferman has filed Form 4 at TARA (Protara Therapeutics, Inc.) as CEO and President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.